Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis

Quality in Primary Care

Volumn 18, Issue 6, 2010, Pages 379-389

  Li, Michelle Pui Ming ^a   Jelinek, George A ^a   Weiland, Tracey J ^a   Mackinlay, Claire A ^a   Dye, Sherelle ^b   Gawler, Ian ^b   Mcouns, H S ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Gawler Foundation   (Australia)

Author keywords

Health related quality of life; Lifestyle modification; MSQOL; Multiple sclerosis

Indexed keywords

ARTICLE; AUSTRALIA; CLINICAL TRIAL; FEMALE; HEALTH PROMOTION; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MALE; MULTIPLE SCLEROSIS; PUBLIC HEALTH SERVICE; QUALITY OF LIFE;

FEMALE; HEALTH PROMOTION; HEALTH RESORTS; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MULTIPLE SCLEROSIS; QUALITY OF LIFE; VICTORIA;

EID: 79952128453     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Polman CH and Uitdehaag BMJ. Drug treatment of multiple sclerosis. Western Journal of Medicine 2000; 173: 398.
2. Compston A and Coles A. Multiple sclerosis. The Lancet 2008; 372: 1502-17.
3. Dahl OP, Stordal E, Lyderson S and Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord- Trøndelag County, Norway. Multiple Sclerosis 2009; 15: 1495-501.
4. Lublin FD. Clinical features and diagnosis of multiple sclerosis. Neurologic Clinics 2005; 23: 1-15. (Pubitemid 40126912)
5. Ford HL, Gerry E, Johnson M and Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. Journal of Neurology 2002; 249: 260-5. (Pubitemid 34212266)
6. Ragonese P, Aridon P, Salemi G et al. Mortality in multiple sclerosis: a review. European Journal of Neurology 2008; 15: 123-7.
7. Bronnum-Hansen H, Koch-Henriksen N and Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 11: 11.
8. Chaudhuri A and Behan PO. Treatment of multiple sclerosis: beyond the NICE guidelines. QJM 2005; 98: 373-8. (Pubitemid 40663126)
9. Clegg A and Bryant J. Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. Expert Opinion on Pharmacotherapy 2001; 2: 623-39. (Pubitemid 32427757)
10. Esmonde L and Long AF. Complementary therapy use by persons with multiple sclerosis: benefits and research priorities. Complementary Therapies in Clinical Practice 2008; 14: 176-84.
11. Parkin D, Jacoby A, McNamee P et al. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 144-9. (Pubitemid 30245835)
12. Stuifbergen A, Becker H, Rogers S et al. Promoting wellness for women with multiple sclerosis. Journal of Neuroscience Nursing 1999; 31: 73.
13. Sherri AO. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occupational Therapy International 2009; 16: 57-70.
14. Swank RL and Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. The Lancet 1990; 336: 37-9. (Pubitemid 20207879)
15. Swank RL and Goodwin J. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003; 19: 161-2. (Pubitemid 36194478)
16. Swank RL. Multiple sclerosis: a correlation of its incidence with dietary fat. American Journal of the Medical Sciences 1950; 220: 421-30.
17. Smolders J, Damoiseaux J, Menheere P and Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology 2008; 194: 7-17.
18. Bjarnadottir OH, Konradsdottir AD, Reynisdottir K and Olafsson E. Multiple sclerosis and brief moderate exercise. A randomised study. Multiple Sclerosis 2007; 13: 776-82. (Pubitemid 47074102)
19. Dalgas U, Stenager E and Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Multiple Sclerosis 2008; 14: 35-53. (Pubitemid 351541395)
20. Brown RF, Tennant CC, Sharrock M et al. Relationship between stress and relapse in multiple sclerosis: part I. Important features. Multiple Sclerosis 2006; 12: 453-64. (Pubitemid 44132586)
21. Malcomson KS, Dunwoody L and Lowe-Strong AS. Psychosocial interventions in people with multiple sclerosis: a review. Journal of Neurology 2007; 254: 1-13. (Pubitemid 46295082)
22. Ghafari S, Ahmadi F, Nabavi M et al. Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis. Journal of Clinical Nursing 2009; 18: 2171-9.
23. Jelinek GA and Hassed CS. Managing multiple sclerosis in primary care: are we forgetting something? Quality in Primary Care 2009; 17: 55-61.
24. Stuifbergen AK, Becker H, Blozis G et al. A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Archives of Physical Medicine and Rehabilitation 2003; 84: 467-76. (Pubitemid 36417644)
25. Ennis M, Thain J, Boggild M et al. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clinical Rehabilitation 2006; 20: 783-92. (Pubitemid 46940503)
26. Jelinek GA. The Overcoming Multiple Sclerosis Recovery Program, www.overcomingmultiplesclerosis.org (accessed 20 May 2009).
27. Jelinek GA. Taking Control of Multiple Sclerosis: natural and medical therapies to prevent its progression. Lancaster, UK: Fleetfoot Books, 2005.
28. Jelinek GA. Overcoming Multiple Sclerosis: an evidencebased guide to recovery. Sydney: Allen and Unwin, 2010.
29. Vickrey BG, Hays RD, Harooni R et al. A health-related quality of life measure for multiple sclerosis. Quality of Life Research 1995; 4: 187-206.
30. Swank RL and Dugan BB. The Multiple Sclerosis Diet Book. A low fat diet for the treatment of MS. New York: Doubleday, 1987.
31. Solari A, Filippini G, Mendozzi L et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. Journal of Neurology, Neurosurgery, and Psychiatry 1999; 67: 158-62. (Pubitemid 29326944)
32. Yamamoto T, Ogata K, Katgishi M et al. Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument. Rinsho Shinkeigaku 2004; 44: 417-21. (Pubitemid 40036636)
33. Amato MP, Ponziani G, Rossi F et al. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Multiple Sclerosis 2001; 7: 340-4. (Pubitemid 33026260)
34. Janardhan V and Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of the Neurological Sciences 2002; 205: 51-8. (Pubitemid 36158993)
35. Hart S, Fonareva I, Merluzzi N and Mohr D. Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Quality of Life Research 2005; 14: 695-703. (Pubitemid 40576856)
36. Romberg A, Virtanen A and Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. Journal of Neurology 2005; 252: 839-45. (Pubitemid 40984862)
37. Saccardi R, Mancardi GL, Solari A et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601-7. (Pubitemid 40387065)
38. Cohen JW. Statistical Power Analysis for the Behavioral Sciences (2e). Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
39. Coons SJ and Kaplan RM. Quality of life assessment: understanding its use as an outcome measure. Hospital Formulary 1993; 28: 486-90,492,497-8.
40. Benito-Leon J, Morales JM, Rivera-Navarro J and Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disability and Rehabilitation 2003; 25: 1291-303.
41. Ozakbas S, Akdede BB, Kosehasanogullari G et al. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy. Journal of the Neurological Sciences 2007; 256: 30-4. (Pubitemid 46560621)
42. Nortvedt MW and Riise T. The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis 2003; 9: 63-72. (Pubitemid 36253699)
43. Solari A, Ferrari G and Radice D. A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. Journal of Neurological Sciences 2006; 243: 13-20.
44. McCabe MP, Stokes M and McDonald E. Changes in quality of life and coping among people with multiple sclerosis over a two-year period. Psychology, Health and Medicine 2009; 14: 86-96.
45. Vazirinejad R and Lilley JM. Measuring perceived quality of life to assess health needs among people with MS: a community study in Derbyshire, UK. Iranian Journal of Public Health 2008; 37: 29-35.
46. O'Connor P, Lee L, Ng PT et al. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology 2001; 57: 889-91. (Pubitemid 32845514)
47. Pittock SJ, Mayr WT, McClelland RL et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Archives of Neurology 2004; 61: 679-86. (Pubitemid 38637684)
48. Tepavcevic DK, Kostic J, Basuroski ID et al. The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Multiple Sclerosis 2008; 14: 1131-6.
49. Orton SM, Herrera BM, Yee IM et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. The Lancet Neurology 2006; 5(11): 932-6. (Pubitemid 44556546)